- HMS Community Values
- Introduction to Clinical Research Training
- Medical Education
- United Kingdom Clinical Scholars Research Training
- Vanderbilt Hall
- What it Means to Be a Harvard Doctor
- Diversity Commitment
- Tuition, Fees, & Expenses
- Interview Day
- The Neighborhood
- Admissions FAQs
- Contact Admissions
- Financial Aid
- Office of the Registrar
- Campus Planning and Facilities
- Ombuds Office
- Committee on Microbiological Safety
- Human Resources
- The Academy
- Office for Academic and Clinical Affairs
- Joint Committee on the Status of Women
- Global Health Research Core
- Global Clinical Scholars Research Training Program
- HMA Standing Committee on Animals
- Office of Research Compliance
- Harvard Medical School Event Calendar
- Office of Diversity RIA Program
- The Dean's Perspective
- Department of Pathology
- Harvard Mahoney Neuroscience Institute
- OHRA Home
- Office of Research Subject Protection
- Tools and Technology
- Alumni Association
- Cancer Biology & Therapeutics Program
- Celiac Program
- Department of Medicine
- HMS Information Technology
- HMS TransMed Program
- Introduction to the Practice of American Medicine
- Office of Communications & External Relations
- Big Data In Healthcare
- Institutional Planning and Policy
- Master of Medical Sciences In Clinical Investigation
- Office of Global Education
- Portugal Clinical Scholars Research Training Program
- Safety Quality Informatics and Leadership
- South American Clinical Research Training Program | SACRT
- Shenzhen-HMS Initiative in International Education
- test page
- HMS Foundation Funds
- Contact @HMS
- Office of Global Education
- Human Resources
- Jobs @ HMS
- Dental Medicine
- Harvard University
- Contact us
Harnessing Ear Power
Deep in the inner ear of mammals is a natural battery — a chamber filled with ions that produces an electrical potential to drive neural signals. In the journal Nature Biotechnology, a team of researchers from Harvard Medical School, MIT, the Massachusetts Eye and Ear Infirmary (MEEI) and the Harvard-MIT Division of Health Sciences and Technology (HST) demonstrates for the first time that this battery could power implantable electronic devices without impairing hearing.
The devices could monitor biological activity in the ears of people with hearing or balance impairments, or responses to therapies. Eventually, they might even deliver therapies themselves.
In experiments, Konstantina Stankovic, HMS assistant professor of otology and laryngology at MEEI, and HST graduate student Andrew Lysaght implanted electrodes in the biological batteries in guinea pigs’ ears. Attached to the electrodes were low-power electronic devices developed by MIT researchers. After the implantation, the guinea pigs responded normally to hearing tests, and the devices were able to wirelessly transmit data about the chemical conditions of the ear to an external receiver.
“In the past, people have thought that the space where the high potential is located is inaccessible for implantable devices, because potentially it’s very dangerous if you encroach on it,” said Stankovic, an otologic surgeon at MEEI and Massachusetts General Hospital. “We have known for 60 years that this battery exists and that it’s really important for normal hearing, but nobody has attempted to use this battery to power useful electronics.”
The ear converts a mechanical force — the vibration of the eardrum — into an electrochemical signal that can be processed by the brain; the biological battery is the source of that signal’s current. Located in the part of the ear called the cochlea, the battery chamber is divided by a membrane, some of whose cells are specialized to pump ions. An imbalance of potassium and sodium ions on opposite sides of the membrane, together with the particular arrangement of the pumps, creates an electrical voltage.
Although the voltage is the highest in the body (outside of individual cells, at least), it’s still very low. Moreover, in order not to disrupt hearing, a device powered by the biological battery can harvest only a small fraction of its power. Low-power chips, however, are precisely the area of expertise of Anantha Chandrakasan’s group at MIT’s Microsystems Technology Laboratories (MTL).
The MTL researchers — Chandrakasan, who heads MIT’s Department of Electrical Engineering and Computer Science; his former graduate student Patrick Mercier, who’s now an assistant professor at the University of California at San Diego; and Saurav Bandyopadhyay, a graduate student in Chandrakasan’s group — equipped their chip with an ultralow-power radio transmitter: After all, an implantable medical monitor wouldn’t be much use if there were no way to retrieve its measurements.
But while the radio is much more efficient than those found in cellphones, it still couldn’t run directly on the biological battery. So the MTL chip also includes power-conversion circuitry — like the boxy plug on a phone charger — that gradually builds up charge in a capacitor. The voltage of the biological battery fluctuates, but it would take the control circuit somewhere between 40 seconds and four minutes to amass enough charge to power the radio. Thus, the frequency of the signal itself indicated electrochemical properties of the inner ear.
To reduce its power consumption, the control circuit had to be drastically simplified, but like the radio, it still required a higher voltage than the biological battery could provide. Once the control circuit was operational, it could drive itself; the problem was getting it up and running.
The MTL researchers solve that problem with a one-time burst of radio waves. “In the very beginning, we need to kick-start it,” Chandrakasan says. “Once we do that, we can be self-sustaining. The control runs off the output.”
Stankovic, who maintains an affiliation with HST, and Lysaght implanted electrodes attached to the MTL chip on both sides of the membrane in the biological battery of each guinea pig’s ear. In the experiments, the chip itself remained outside the guinea pig’s body, but it’s small enough to nestle in the cavity of the middle ear.
Cliff Megerian, chairman of the otolaryngology department at Case Western Reserve University, says that he sees three possible applications of the researchers’ work: in cochlear implants, diagnostics and implantable hearing aids. “The fact that you can generate the power for a low voltage from the cochlea itself raises the possibility of using that as a power source to drive a cochlear implant,” Megerian says. “Imagine if we were able to measure that voltage in various disease states. There would potentially be a diagnostic algorithm for aberrations in that electrical output.”
“I’m not ready to say that the present iteration of this technology is ready,” Megerian cautions. But he adds that, “If we could tap into the natural power source of the cochlea, it could potentially be a driver behind the amplification technology of the future.”
The work was funded in part by the Focus Center Research Program, the National Institute on Deafness and Other Communication Disorders, and the Bertarelli Foundation.
Larry Hardesty is a science writer at the MIT News Office.
Stay informed via email on the latest news, research, and
media from Harvard Medical School.